These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 32225123

  • 1. Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival.
    Su YL, Luo HL, Huang CC, Liu TT, Huang EY, Sung MT, Lin JJ, Chiang PH, Chen YT, Kang CH, Cheng YT.
    Cells; 2020 Mar 26; 9(4):. PubMed ID: 32225123
    [Abstract] [Full Text] [Related]

  • 2. NTRK3 exhibits a pro-oncogenic function in upper tract urothelial carcinomas.
    Lim LM, Lee YC, Lin TW, Hong ZX, Hsu WC, Ke HL, Hwang DY, Chung WY, Li WM, Lin HH, Kuo HT, Huang AM.
    Kaohsiung J Med Sci; 2024 May 26; 40(5):445-455. PubMed ID: 38593276
    [Abstract] [Full Text] [Related]

  • 3. Flaccidoxide-13-Acetate Extracted from the Soft Coral Cladiella kashmani Reduces Human Bladder Cancer Cell Migration and Invasion through Reducing Activation of the FAK/PI3K/AKT/mTOR Signaling Pathway.
    Neoh CA, Wu WT, Dai GF, Su JH, Liu CI, Su TR, Wu YJ.
    Molecules; 2017 Dec 27; 23(1):. PubMed ID: 29280977
    [Abstract] [Full Text] [Related]

  • 4. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P, Levidou G, Trigka EA, Prekete N, Karlou M, Thymara I, Sakellariou S, Fragkou P, Isaiadis D, Pavlopoulos P, Patsouris E, Saetta AA.
    BJU Int; 2012 Dec 27; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [Abstract] [Full Text] [Related]

  • 5. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 27; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma.
    Wu N, Du Z, Zhu Y, Song Y, Pang L, Chen Z.
    Technol Cancer Res Treat; 2018 Jan 01; 17():1533033818758772. PubMed ID: 29463194
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma.
    Bagrodia A, Krabbe LM, Gayed BA, Kapur P, Bernstein I, Xie XJ, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclerq N, Haitel A, Roscigno M, Bolenz C, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Margulis V.
    Urology; 2014 Nov 01; 84(5):1134-40. PubMed ID: 25443916
    [Abstract] [Full Text] [Related]

  • 11. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J, Zhao X, Jiang H, Yang T, Li D, Yang X, Jia A, Ma Y, Qian Z.
    Tissue Cell; 2022 Aug 01; 77():101817. PubMed ID: 35679685
    [Abstract] [Full Text] [Related]

  • 12. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
    Zhang M, Liu S, Chua MS, Li H, Luo D, Wang S, Zhang S, Han B, Sun C.
    Cell Death Dis; 2019 Aug 13; 10(8):612. PubMed ID: 31406106
    [Abstract] [Full Text] [Related]

  • 13. Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Bacigalupo ML, Manzi M, Espelt MV, Gentilini LD, Compagno D, Laderach DJ, Wolfenstein-Todel C, Rabinovich GA, Troncoso MF.
    J Cell Physiol; 2015 Jun 13; 230(6):1298-309. PubMed ID: 25469885
    [Abstract] [Full Text] [Related]

  • 14. Impact of PI3K-AKT-mTOR Signaling Pathway Up-regulation on Prognosis of Penile Squamous-Cell Carcinoma: Results From a Tissue Microarray Study and Review of the Literature.
    Azizi M, Tang DH, Verduzco D, Peyton CC, Chipollini J, Yuan Z, Schaible BJ, Zhou JM, Johnstone PA, Giuliano A, Dhillon J, Spiess PE.
    Clin Genitourin Cancer; 2019 Feb 13; 17(1):e80-e91. PubMed ID: 30318447
    [Abstract] [Full Text] [Related]

  • 15. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ, Lin S, Liu JN, Zhang MB, Du YT, Zhang DD, Xu WH, Wang HB.
    J Cell Physiol; 2019 Aug 13; 234(10):18587-18601. PubMed ID: 30953349
    [Abstract] [Full Text] [Related]

  • 16. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin.
    Liu C, Feng X, Wang B, Wang X, Wang C, Yu M, Cao G, Wang H.
    Cancer Sci; 2018 Mar 13; 109(3):688-698. PubMed ID: 29284199
    [Abstract] [Full Text] [Related]

  • 17. Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells.
    Yang MH, Jung SH, Um JY, Kumar AP, Sethi G, Ahn KS.
    Life Sci; 2022 Apr 15; 295():120395. PubMed ID: 35181309
    [Abstract] [Full Text] [Related]

  • 18. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH, Yang J, Gao LK, Min J, Tang JM, Hu M, Li Y, Li ST, Chen J, Hong L.
    Oncol Rep; 2019 Feb 15; 41(2):917-927. PubMed ID: 30483796
    [Abstract] [Full Text] [Related]

  • 19. Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients.
    Wang N, She J, Liu W, Shi J, Yang Q, Shi B, Hou P.
    Cell Cycle; 2015 Feb 15; 14(5):732-43. PubMed ID: 25590580
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T, Chen H, Wang P, Yang N, Bao J.
    Cancer Biother Radiopharm; 2020 Nov 15; 35(9):661-672. PubMed ID: 32275162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.